CSBR insider filings

CHAMPIONS ONCOLOGY, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-09. Screen CSBR transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
ACKERMAN JOEL — Director2——3
Mendelson Daniel Newman — Director1——1
SIDRANSKY DAVID — Director1——1
TOBIN SCOTT R — Director, 10% owner1——1

Recent insider filings — CHAMPIONS ONCOLOGY, INC.

FiledFormInsiderReported transactionsSource
2026-11-094SIDRANSKY DAVID — DirectorGrant/award (A): 31,216 (derivative) @ $4.76EDGAR
2026-11-094Mendelson Daniel Newman — DirectorGrant/award (A): 20,291 (derivative) @ $4.76EDGAR
2026-11-094TOBIN SCOTT R — Director, 10% ownerGrant/award (A): 37,460 (derivative) @ $4.76EDGAR
2026-11-094ACKERMAN JOEL — DirectorGrant/award (A): 31,216 (derivative) @ $4.76EDGAR
2026-10-164ACKERMAN JOEL — DirectorOption exercise (M): 69,794 @ $1.60 · Option exercise (M): 69,794 (derivative) @ $1.60EDGAR
2026-01-304Brainin Robert Lawrence — CEO, DirectorGrant/award (A): 225,000 (derivative) @ $7.80 · Grant/award (A): 62,500 (derivative) @ $7.80 · Grant/award (A): 62,500 (derivative) @ $7.80 · Grant/award (A): 150,000 (derivative) @ $7.80 · Grant/award (A): 100,000 (derivative) @ $7.80 · Grant/award (A): 100,000 (derivative) @ $7.80EDGAR
2026-01-304Brainin Robert Lawrence — DirectorGrant/award (A): 9,901 (derivative) @ $10.10 · Grant/award (A): 14,130 (derivative) @ $7 · Grant/award (A): 19,070 (derivative) @ $5.51 · Grant/award (A): 23,030 (derivative) @ $4.64EDGAR
2025-11-074Breitfeld Philip P. — DirectorGrant/award (A): 13,790 (derivative) @ $6.80EDGAR
2025-11-074Mendelson Daniel Newman — DirectorGrant/award (A): 13,790 (derivative) @ $6.80EDGAR
2025-11-074SIDRANSKY DAVID — DirectorGrant/award (A): 21,216 (derivative) @ $6.80EDGAR
2025-11-074ACKERMAN JOEL — DirectorGrant/award (A): 21,216 (derivative) @ $6.80EDGAR
2025-11-074TOBIN SCOTT R — Director, 10% ownerGrant/award (A): 25,460 (derivative) @ $6.80EDGAR
2025-11-064ACKERMAN JOEL — DirectorOption exercise (M): 94,405 @ $2.10 · Option exercise (M): 94,405 (derivative) @ $2.10EDGAR
2025-04-024Breitfeld Philip P. — DirectorOther (J): 4,150 @ $0EDGAR
2024-11-184Breitfeld Philip P. — DirectorGrant/award (A): 18,715 (derivative) @ $4.64EDGAR
2024-11-184Mendelson Daniel Newman — DirectorGrant/award (A): 21,590 (derivative) @ $4.64EDGAR
2024-11-184SIDRANSKY DAVID — DirectorGrant/award (A): 21,880 (derivative) @ $4.64EDGAR
2024-11-184ACKERMAN JOEL — DirectorGrant/award (A): 43,190 (derivative) @ $4.64EDGAR
2024-11-184TOBIN SCOTT R — Director, 10% ownerGrant/award (A): 34,550 (derivative) @ $4.64EDGAR
2024-11-014ACKERMAN JOEL — DirectorOption exercise (M): 88,470 @ $2.10 · Option exercise (M): 16,667 @ $5.43 · Option exercise (M): 88,470 (derivative) @ $2.10 · Option exercise (M): 16,667 (derivative) @ $5.43EDGAR
2024-04-014Davis Brady — PresidentGrant/award (A): 135,000 (derivative) @ $6.50 · Grant/award (A): 7,500 (derivative) @ $6.50 · Grant/award (A): 68,000 (derivative) @ $6.50EDGAR
2024-01-164Mendelson Daniel Newman — DirectorPurchase (P): 1,000 @ $6.50EDGAR
2024-01-124Mendelson Daniel Newman — DirectorPurchase (P): 2,000 @ $6.27EDGAR
2024-01-114Mendelson Daniel Newman — DirectorPurchase (P): 2,944 @ $6.31EDGAR
2024-01-104Mendelson Daniel Newman — DirectorPurchase (P): 3,000 @ $6.25EDGAR
2024-01-094Mendelson Daniel Newman — DirectorPurchase (P): 1,000 @ $6.15EDGAR
2024-01-084Mendelson Daniel Newman — DirectorPurchase (P): 2,000 @ $6.09EDGAR
2024-01-084Mendelson Daniel Newman — DirectorPurchase (P): 3,000 @ $6.12EDGAR
2024-01-054ACKERMAN JOEL — DirectorOption exercise (M): 114,552 @ $2.10 · Option exercise (M): 100,000 (derivative) @ $2.10 · Option exercise (M): 14,552 (derivative) @ $2.10EDGAR
2024-01-044Mendelson Daniel Newman — DirectorPurchase (P): 500 @ $5.83EDGAR
2023-12-264Mendelson Daniel Newman — DirectorPurchase (P): 2,500 @ $4.92EDGAR
2023-12-214Mendelson Daniel Newman — DirectorPurchase (P): 2,100 @ $4.82EDGAR
2023-12-204Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $4.75EDGAR
2023-11-074Breitfeld Philip P. — DirectorGrant/award (A): 15,495 (derivative) @ $5.51EDGAR
2023-11-074Mendelson Daniel Newman — DirectorGrant/award (A): 26,220 (derivative) @ $5.51EDGAR
2023-11-074SIDRANSKY DAVID — DirectorGrant/award (A): 15,495 (derivative) @ $5.51EDGAR
2023-11-074ACKERMAN JOEL — DirectorGrant/award (A): 35,750 (derivative) @ $5.51EDGAR
2023-11-074TOBIN SCOTT R — Director, 10% ownerGrant/award (A): 28,600 (derivative) @ $5.51EDGAR
2023-10-164Mendelson Daniel Newman — DirectorPurchase (P): 4,000 @ $6.16EDGAR
2023-10-164Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $6.22EDGAR
2023-10-164Mendelson Daniel Newman — DirectorPurchase (P): 1,500 @ $5.95EDGAR
2023-10-134Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $6.40EDGAR
2023-10-114Mendelson Daniel Newman — DirectorPurchase (P): 1,100 @ $6.41EDGAR
2023-10-104Mendelson Daniel Newman — DirectorPurchase (P): 1,530 @ $6.48EDGAR
2023-10-064Mendelson Daniel Newman — DirectorPurchase (P): 2,000 @ $6.47EDGAR
2023-10-044Mendelson Daniel Newman — DirectorPurchase (P): 2,500 @ $6.30EDGAR
2023-10-044Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $6.40EDGAR
2023-09-274Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $5.65EDGAR
2023-09-254Mendelson Daniel Newman — DirectorPurchase (P): 5,000 @ $5.51EDGAR
2023-09-254Mendelson Daniel Newman — DirectorPurchase (P): 3,812 @ $5.50EDGAR

Recent 8-K events — CHAMPIONS ONCOLOGY, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-09-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-09-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-218-K9.01 — Financial Statements and ExhibitsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CSBR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs